EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 11th, 2020 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Executive Severance Benefits Agreement (the “Agreement”) is entered into this 4th day of May, 2020 (the “Effective Date”) between Constantina Gullotta (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.
CONSULTING AGREEMENT Effective Date: May 2, 2020 Expiration Date: December 31, 2020Consulting Agreement • August 11th, 2020 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Consulting Agreement (the “Consulting Agreement”) is entered into by and between Sunesis Pharmaceuticals, Inc. (“SUNESIS”) and William P. Quinn (“CONSULTANT”) in connection with and as Exhibit A to the Agreement (the “Agreement”) between the parties of even date herewith. SUNESIS desires to have CONSULTANT serve as a non-exclusive consultant to SUNESIS under the terms of this Agreement. This Consulting Agreement is effective immediately upon the expiration of CONSULTANT’s service with SUNESIS as an employee, such that there is no break in service between his termination of employment and the effectiveness of this Consulting Agreement.
